SCHEMBL16909458

SCHEMBL16909458

Cc1nc2ccc(-c3cnc(N4CCC[C@H](C(=O)O)C4)nc3)cn2c1Cc1ccccc1OC(F)F

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.42
ALKBH1 Q13686 1/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DGAT2 Q96PD7 8/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
SLC2A1 P11166 1/20 0.37
TSHR P16473 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
ITGB2 P05107 1/20 0.35
ICAM1 P05362 1/20 0.35
ITGAL P20701 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16909460 1.00 TNF (0.42) TNFALKBH1KDM4EALDH1A1MEN1
SCHEMBL16909435 1.00 TNF (0.42) TNFALKBH1KDM4EALDH1A1MEN1
SCHEMBL16909897 0.96 TNF (0.42) TNFALKBH1KDM4EALDH1A1MEN1
SCHEMBL17666760 0.94 TNF (0.40) TNFALKBH1KDM4EHSD17B10DGAT2
SCHEMBL16909444 0.93 ALKBH1 (0.42) TNFALKBH1DGAT2SLC2A1
SCHEMBL16909640 0.91 ALKBH1 (0.41) TNFALKBH1KDM4EALDH1A1HSD17B10
SCHEMBL16874440 0.91 TNF (0.39) TNFALKBH1KDM4EALDH1A1MEN1
SCHEMBL16874490 0.91 TNF (0.39) TNFALKBH1KDM4EALDH1A1MEN1
SCHEMBL16909724 0.89 TNF (0.41) TNFALKBH1KDM4EALDH1A1MEN1
SCHEMBL16909802 0.89 TNF (0.41) TNFALKBH1KDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9309243-B2 Imidazopyridine derivatives as modulators of TNF activity UCB BIOPHARMA SPRL (BE) 2016-04-12 US claimed
EP-2872508-B1 IMIDAZOPYRIDINE DERIVATIVES AS MODULATORS OF TNF ACTIVITY UCB BIOPHARMA SPRL (BE) 2018-08-29 EP disclosed
US-9309243-B2 Imidazopyridine derivatives as modulators of TNF activity UCB BIOPHARMA SPRL (BE) 2016-04-12 US disclosed
US-20150203486-A1 Imidazopyridine Derivatives as Modulators of TNF Activity UCB Biopharma SPRL a corporation 2015-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203486-A1 Imidazopyridine Derivatives as Modulators of TNF Activity TNF, TNFRSF1A, IL1A TNF 1/4885ALKBH1 4341/4885KDM4E 4217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.